DaVita Receives a Buy from William Blair


William Blair analyst Margaret Kaczor maintained a Buy rating on DaVita (NYSE: DVA) today. The company’s shares opened today at $67.73.

According to TipRanks.com, Kaczor is ranked #626 out of 4822 analysts.

DaVita has an analyst consensus of Moderate Buy, with a price target consensus of $77.

See today’s analyst top recommended stocks >>

The company has a one-year high of $80.71 and a one-year low of $52.51. Currently, DaVita has an average volume of 1.56M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

DaVita, Inc. engages in the provision of medical care services. It operates through the following US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts